​
Login / Signup
Jennifer L Plahovinsak
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 6
Top Topics
Double Blind
Primary Care
Phase Iii
Clinical Trial
Top Venues
Clinical pharmacology and therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Demi L MacLennan
,
Jennifer L Plahovinsak
,
Rob J MacLennan
,
Carolynn Thomas Jones
Clinical Trial Site Perspectives and Practices on Study Participant Diversity and Inclusion.
Clinical pharmacology and therapeutics
113 (3) (2023)
Demi L MacLennan
,
Jennifer L Plahovinsak
,
Rob J MacLennan
,
Carolynn Thomas Jones
Clinical Trial Site Perspectives and Practices on Study Participant Diversity and Inclusion.
Clinical pharmacology and therapeutics
113 (3) (2023)
Demi L MacLennan
,
Jennifer L Plahovinsak
,
Rob J MacLennan
,
Carolynn Thomas Jones
Clinical Trial Site Perspectives and Practices on Study Participant Diversity and Inclusion.
Clinical pharmacology and therapeutics
113 (3) (2023)
Demi L MacLennan
,
Jennifer L Plahovinsak
,
Rob J MacLennan
,
Carolynn Thomas Jones
Clinical Trial Site Perspectives and Practices on Study Participant Diversity and Inclusion.
Clinical pharmacology and therapeutics
113 (3) (2023)
Demi L MacLennan
,
Jennifer L Plahovinsak
,
Rob J MacLennan
,
Carolynn T Jones
Clinical Trial Site Perspectives and Practices on Study Participant Diversity and Inclusion.
Clinical pharmacology and therapeutics
(2022)
Demi L MacLennan
,
Jennifer L Plahovinsak
,
Rob J MacLennan
,
Carolynn Thomas Jones
Clinical Trial Site Perspectives and Practices on Study Participant Diversity and Inclusion.
Clinical pharmacology and therapeutics
(2022)